Advanced Medical Equipment & Technology

IMRIS Inc gives Q1 2015 revenue guidance; gives FY 2015 revenue guidance below analysts' estimates

IMRIS Inc:Expects Q1 2015 revenues will be in the range of $3.5 mln to $4.5 mln.Expects FY 2015 revenues to be in the range of $40 mln to $55 mln.FY 2015 revenue of $60 mln - Thomson Reuters I/B/E/S.

Wednesday, 4 Mar 2015 08:01am EST

Exini Diagnostics AB appoints Henrik Perlmutter as chairman

Exini Diagnostics AB:Appointed Henrik Perlmutter as chairman until forthcoming general meeting on April 27 due to sick leave of Fredrik Lindgren.

Wednesday, 4 Mar 2015 05:18am EST

ZELTIQ Aesthetics Inc raises FY 2015 revenue guidance

ZELTIQ Aesthetics Inc:Increases FY 2015 revenue guidance in the range of $230 million to $235 million which would represent about 35pct year-over-year growth.FY 2015 revenue of $224 million - Thomson Reuters I/B/E/S.

Tuesday, 3 Mar 2015 04:05pm EST

Veeva Systems Inc gives Q1, FY 2016 guidance; earnings guidance above analysts' estimates

Veeva Systems Inc:Expects Q1 2016 total revenues between $87 and $88 million.Expects Q1 2016 Non-GAAP operating income between $23 and $24 million.Expects Q1 2016 Non-GAAP fully diluted net income per share of $0.10.Expects FY 2016 Total revenues between $390 and $395 million.Expects FY 2016...

Tuesday, 3 Mar 2015 04:03pm EST

Restructuring & Reorganization

Expansion & New Markets

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.